The impact of bariatric surgery beyond its effect on weight loss has entailed a change in the way of regarding it. The term metabolic surgery has become more popular to designate those interventions that aim at resolving diseases that have been traditionally considered as of exclusive medical management, such as type 2 diabetes mellitus (T2D). Recommendations for metabolic surgery have been largely addressed and discussed in worldwide meetings, but no definitive consensus has been reached yet. Rates of diabetes remission after metabolic surgery have been one of the most debated hot topics, with heterogeneity being a current concern. This review aims to identify and clarify controversies regarding metabolic surgery, by focusing on a critical analysis of T2D remission rates achieved with different bariatric procedures, and using different criteria for its definition. Indications for metabolic surgery for patients with T2D who are not morbidly obese are also discussed. © 2013 SEEN.
CITATION STYLE
Ramos-Leví, A. M., & Rubio Herrera, M. A. (2014). Metabolic surgery: Quo Vadis? Endocrinología y Nutrición (English Edition), 61(1), 35–46. https://doi.org/10.1016/j.endoen.2014.01.012
Mendeley helps you to discover research relevant for your work.